Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study
Giorgio Dalla Volta,Antonio Russo,Marcello Silvestro,Raffaele Ornello,Valeria Caponnetto,Simona Sacco,Paola Zavarise,Matteo Cortinovis,Flavia Lo Castro,Simona Guerzoni,Maria Pia Prudenzano,Martino Gentile,Roberto De Icco,Gloria Vaghi,Cristina Tassorelli,Marina De Tommaso,Stefania Scannicchio,Innocenzo Rainero,Antonio Granato,Federica Nicoletta Sepe,Delfina Ferrandi,Valentina Rebecchi,Massimo Alessandri,Andrea Burgalassi,Marina Romozzi,Alfonsina Casalena,Alberto Chiarugi,Pierangelo Geppetti,Luigi Francesco Iannone
DOI: https://doi.org/10.1177/03331024241299453
2024-11-28
Cephalalgia
Abstract:Cephalalgia, Volume 44, Issue 11, November 2024. BackgroundMigraine with aura (MwA) is a debilitating disorder characterized by paroxysmal attacks of pain preceded or accompanied by reversible neurological symptoms. While the pathophysiology remains unclear, trigeminovascular system activation and cortical spreading depression have been implicated. This study aims to comprehensively investigate and characterize the diverse clinical features and manifestations of aura, as well as the types of acute medications self-administered for aura management.MethodsA multicenter, cross-sectional study was conducted using data from the Italian Headache Registry (RICe). Aura characteristics, frequency, duration and associated migraine premonitory symptoms were collected. Acute medication use and timing (headache or aura phase) were assessed.ResultsThe study included 272 patients with a diagnosis of MwA. Most patients (99.3%) experienced typical aura symptoms, with visual aura (96.3%) being the most prevalent, followed by sensory (33.0%) and speech and/or language aura (25.6%). Brainstem aura (8.5%) and motor aura (1.8%) were less common. Notably, 13.0% of patients reported aura relapses within 24 hours. Triptans (39.7%), non-steroidal anti-inflammatory drugs (47.8%) and nutraceuticals (59.9%) were commonly used for acute aura management.ConclusionsThis study reports several different aura manifestations, highlighting atypical features, aura relapse rates and treatment approaches for aura. These findings could contribute to a deeper understanding of aura and its management in clinical settings.
neurosciences,clinical neurology